Endocrinology and Metabolism Treatments
The Department of Diabetes, Endocrinology & Metabolism at City of Hope provides comprehensive care for patients with diabetes. This disease interferes with the body’s ability to turn sugar into usable energy.
Diabetes and obesity are significant health challenges in the U.S. and worldwide. City of Hope strives to make a difference for our patients through high-quality treatment and innovative science. Over half a century, we have built a reputation as one of the leading centers for diabetes research. Our medical team offers leading-edge diabetes care driven by City of Hope’s trademark commitment to compassion.
In addition to treating and studying diabetes, City of Hope's Department of Diabetes, Endocrinology & Metabolism within the Arthur Riggs Diabetes & Metabolism Research Institute also provides care and conducts research on a variety of other endocrine and metabolism disorders, including but not limited to:
- Thyroid cancer
- Neuroendocrine tumors (carcinoids, pancreatic endocrine tumors, etc.)
- Management of endocrine complications that can result from cancer treatment
- Prevention and treatment of osteoporosis
- Management of male and female sexual dysfunction
From discovering how insulin works to the first islet cell transplantation, City of Hope has been revolutionizing diabetes treatment for over 50 years.
The Wanek Family Project for Type 1 Diabetes creates powerful new approaches to treating type 1 diabetes that move beyond managing the disease to finding a cure.
Read about the latest developments in diabetes research and treatment as well as inspiring doctor profiles and uplifting patient stories.
Mohamed El-Shahawy, M.D., M.P.H., M.H.A., is Clinical Professor in the Department of Clinical Diabetes, Endocrinology and Metabolism at City of Hope.
Wei Feng, M.D., is a board certified endocrinologist with expertise in many areas such as diabetes, thyroid, pituitary, osteoporosis, PCOS, obesity, lipid disorder, and adrenal disease.
Elena Forouhar, M.D., specializes in treating diabetes & endocrine problems & is board certified in internal medicine & endocrinology/diabetes & metabolism. Her main areas of interest include both type 1 & type 2 diabetes, as well as obesity & metabolic disorders associated with obesity.
Paul Han, D.P.M., M.S., is a Clinical Consultant and a podiatric surgeon at City of Hope.
Fouad R Kandeel, M.D., Ph.D., is the director of the Islet Cell Transplantation Program and Arthur D. Riggs Distinguished Chair in Diabetes & Metabolism Research at City of Hope.
Behrouz Salehian, M.D., is an endocrinologist specializing in treating thyroid disorders, pituitary disorders and neuroendocrine tumors. He is also director of the diabetes cardiovascular risk reduction program at City of Hope.
Raynald Samoa, M.D., is an associate clinical professor, Department of Diabetes, Endocrinology & Metabolism, as well as an Endocrinologist, at City of Hope in Los Angeles, California.
Samar Singh, M.D., is an assistant clinical professor, Department of Diabetes, Endocrinology & Metabolism at City of Hope Orange County.